A. Lorimer

发表

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

P. Macfarlane, I. Ford, C. Packard, 1995 .

Acipimox in combination with low dose cholestyramine for the treatment of type II hyperlipidaemia.

C. Packard, J. Shepherd, A. Lorimer, 1990, British journal of clinical pharmacology.

New surgical approaches to coronary heart disease.

A. Lorimer, W. H. Bain, 1973, Scottish medical journal.

Postprandial lipemia, fenofibrate and coronary artery disease.

C. Packard, S. Pringle, T. Olivecrona, 1990, Atherosclerosis.

Effects of simvastatin on apoB metabolism and LDL subfraction distribution.

C. Packard, B. Griffin, M. Caslake, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolism.

C. Packard, B. Griffin, M. Caslake, 1996, Arteriosclerosis, thrombosis, and vascular biology.

The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.

C. Packard, J. Shepherd, A. Lorimer, 1983, Journal of lipid research.

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995.

P. Macfarlane, I. Ford, C. Packard, 2004, Atherosclerosis. Supplements.

Current Approach to Coronary Artery Surgery

A. Lorimer, M. Millar-Craig, K. Davidson, 1986, Scottish medical journal.

SCREENING EXPERIENCE AND BASE-LINE CHARACTERISTICS IN THE WEST OF SCOTLAND CORONARY PREVENTION STUDY

P. Macfarlane, J. Norrie, C. Packard, 1995 .

Normal Catecholamine Production in a Patient with a Paroxysmally Secreting Phaeochromocytoma

A. Shenkin, A. Lorimer, D. Sinclair, 1991, Annals of clinical biochemistry.

The significance of the abnormal rest Thallium-201 myocardial image in coronary artery disease

W. Greig, A. Lorimer, J. Mckillop, 1979, European Journal of Nuclear Medicine.

Probucol reduces plasma lipid peroxides in man.

C. Packard, K. Oldroyd, G. Tait, 1991, Atherosclerosis.

Calcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid function.

A. Lorimer, G. Beastall, J. Thomson, 1984, British journal of clinical pharmacology.

Oral verapamil does not affect glucose tolerance in non-diabetics.

A. Lorimer, G. Beastall, J. Thomson, 1983, British journal of clinical pharmacology.

Thrombin and plasmin activity in coronary artery disease.

C. Forbes, G. Lowe, M. Small, 1988, British heart journal.

Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients.

H. G. Morgan, C. Packard, J. Shepherd, 1976, Metabolism: clinical and experimental.

Receptor-mediated low density lipoprotein catabolism in man.

C. Packard, J. Shepherd, A. Lorimer, 1979, Journal of lipid research.

Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjects.

C. Packard, J. Shepherd, M. Dominiczak, 1986, Journal of lipid research.

Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects.

C. Packard, J. Shepherd, A. Lorimer, 1982, Atherosclerosis.

Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.

H. G. Morgan, C. Packard, J. Shepherd, 1984, The Journal of clinical investigation.

Fenofibrate Reduces Low Density Lipoprotein Catabolism in Hypertriglyceridemic Subjects

C. Packard, M. Caslake, J. Shepherd, 1985, Arteriosclerosis.

Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension

J. Connell, A. Lorimer, D. Davies, 1992, Journal of hypertension.

INCREASED BLOOD VISCOSITY AND FIBRINOLYTIC INHIBITOR IN TYPE II HYPERLIPOPROTEINAEMIA

C. Forbes, A. Lorimer, C. Prentice, 1982, The Lancet.

Differences between amlodipine and lisinopril in control of clinic and twenty-four hour ambulatory blood pressures

A. Lorimer, M. Rothman, J. Petrie, 1998, Journal of Human Hypertension.

Compliance and adverse event withdrawal: their impact on the West of Scotland Coronary Prevention Study.

P. Macfarlane, J. Kennedy, J. Norrie, 1997, European heart journal.

Beta blockers and verapamil: a cautionary tale.

A. Lorimer, S. Hutchison, S. McAlpine, 1984, British medical journal.

Calcium Antagonists (Calcium Channel Blockers)

A. Lorimer, 1981, Scottish medical journal.

Serum oestradiol and ischaemic heart disease--relationship with myocardial infarction but not coronary atheroma or haemostasis.

C. Forbes, G. Lowe, M. Small, 1985, The Quarterly journal of medicine.

Determinants of blood rheology in type II hyperlipoproteinaemia

C. Forbes, G. Lowe, A. Lorimer, 1981 .

Felodipine extended release in mild to moderate hypertension.

A. Lorimer, B. Westberg, A. Wester, 1991, Current medical research and opinion.

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

P. Macfarlane, I. Ford, C. Packard, 1995, The New England journal of medicine.

Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.

C. Packard, M. Caslake, J. Shepherd, 1989, Metabolism: clinical and experimental.

The effect of a long‐acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis

O. Garden, S. Pringle, D. Carter, 1988, Alimentary pharmacology & therapeutics.

24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo

S. Pringle, A. Lorimer, G. Jackson, 2004, European Journal of Clinical Pharmacology.

Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.

C. Packard, B. Griffin, M. Caslake, 1995, Journal of lipid research.

A Comparison of Atenolol and Long-Acting Trimazosin in Mild to Moderate Essential Hypertension

G. Murray, A. Lorimer, J. Robertson, 1985, Scottish medical journal.

Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.

R. Russell, D. Carter, A. Lorimer, 1984, Gut.

Relation between extent of coronary artery disease and blood viscosity.

I Hutton, J C Barbenel, G D Lowe, 1980, British medical journal.

A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group.

A. Lorimer, H. Tyler, P. Walker, 1989, Journal of human hypertension.

West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials

P. Macfarlane, J. Kennedy, J. Norrie, 1996 .

Percutaneous arterial catheterization for multiple sampling.

A. Lorimer, F. Moran, G. Boyd, 1968, Thorax.

Percutaneous arterial catheterization for multiple sampling

A. Lorimer, F. Moran, G. Boyd, 1967 .

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS).

P. Macfarlane, J. Norrie, C. Packard, 1998, Circulation.

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

C. Packard, A. Gotto, J. Shepherd, 1984, The Journal of clinical investigation.

"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

J. Reid, D. Mcareavey, A. Lorimer, 1984, British medical journal.

Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial.

Joy, E. Sowton, J. Pepper, 1993, Lancet.

Effect of Ciprofibrate on Platelet Aggregation and Fibrinolysis in Patients with Hypercholesterolaemia

I. Simpson, A. Lorimer, I. Walker, 1985, Thrombosis and Haemostasis.

Evaluation of thallium-201 exercise scintigraphy in coronary heart disease.

W. Greig, A. Lorimer, J. Mckillop, 1979, British heart journal.

Haematocrit in Patients Attending a Hypertension Clinic

C. Forbes, G. Lowe, F. Dunn, 1985, Scottish medical journal.

Severity of coronary artery disease and basal fibrinolysis.

C. Forbes, G. Lowe, M. Small, 1987, Haemostasis.

Long‐term comparison of metoprolol and methyldopa in the treatment of hypertension

W. Hillis, J. Stoker, A. Lorimer, 1980, Clinical cardiology.

Comparison of enalapril and atenolol in mild to moderate hypertension.

J. G. Findlay, S. Ball, P. Waller, 1989, The American journal of medicine.

Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia.

W. Hillis, A. Lorimer, T. Lawrie, 1975, British heart journal.

Can the extent of coronary artery disease be predicted from thallium-201 myocardial images?

W. Greig, A. Lorimer, J. Mckillop, 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Blood pressure in a scottish island community

A. Lorimer, V. Hawthorne, C. Gillis, 1969, British medical journal.

Combined drug therapy for familial hypercholesterolemia.

H. G. Morgan, J. Shepherd, A. Lorimer, 1980, Artery.

A Comparison of the Efficacy and Safety of Ramipril and Digoxin Added to Maintenance Diuretic Treatment in Patients with Chronic Heart Failure

S. Pringle, G. Murray, A. Lorimer, 1991, Journal of Cardiovascular Pharmacology.

Association between Myotonic Dystrophy and Primary Hyperparathyroidism

J. Hinnie, A. Lorimer, E. Bell, 1994, The Journal of international medical research.

Cardiology: the development of a managed clinical network

A. Lorimer, C. Baker, 2000, BMJ : British Medical Journal.

Acute Haemodynamic and Platelet Effects of Felodipine in Hypertensive Patients

A. Lorimer, T. Lawrie, I. Walker, 2012, Drugs.

Blood pressure in a Scottish island community.

A. Lorimer, V. Hawthorne, C. Gillis, 1970, British journal of preventive & social medicine.

Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.

S. Taylor, A. Lorimer, J. Lazarus, 1994, Journal of human hypertension.